Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7724)
All Articles published online
|
Publishing Process of This Article
|
Oct 26, 2020 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Arslan U, Yenerçağ M. Relationship between non-alcoholic fatty liver disease and coronary heart disease. World J Clin Cases 2020; 8(20): 4688-4699 [PMID: PMC7642538 DOI: 10.12998/wjcc.v8.i20.4688] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v8/i20/4688.htm |
| Number | Citing Articles |
| 1 |
Andrea Morán-Costoya, Ana M. Proenza, Magdalena Gianotti, Isabel Lladó, Adamo Valle. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver–Adipose Tissue Crosstalk. Antioxidants & Redox Signaling 2021; 35(9): 753 doi: 10.1089/ars.2021.0044
|
| 2 |
Lu Liu, Sen Sun, Xiaohua Li. LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation. Clinics and Research in Hepatology and Gastroenterology 2023; 47(1): 102067 doi: 10.1016/j.clinre.2022.102067
|
| 3 |
Melania Gaggini, Fabrizio Minichilli, Francesca Gorini, Serena Del Turco, Patrizia Landi, Alessandro Pingitore, Cristina Vassalle. FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients. Biomedicines 2022; 11(1): 76 doi: 10.3390/biomedicines11010076
|
| 4 |
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, Jatin Behari, Madhulika Tripathi, Brijesh Kumar Singh. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1433857
|
| 5 |
Carlos Millán-Rodríguez, Carlos Palacios Castelló Palacios Castelló, María de Regla Caballero-Valderrama, Gonzalo Barón Esquivias. Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist. European Cardiology Review 2023; 18 doi: 10.15420/ecr.2023.22
|
| 6 |
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, Jörn M. Schattenberg. Liver stiffness as a cornerstone in heart disease risk assessment. Liver International 2024; 44(2): 344 doi: 10.1111/liv.15801
|
| 7 |
Mohammad Said Ramadan, Vincenzo Russo, Gerardo Nigro, Emanuele Durante-Mangoni, Rosa Zampino. Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective. Journal of Clinical Medicine 2021; 10(8): 1569 doi: 10.3390/jcm10081569
|
| 8 |
Amirhossein Naghipour, Ehsan Amini-Salehi, Mahdi Orang Gorabzarmakhi, Milad Shahdkar, Bahman Fouladi, Iraj Alipourfard, Zahra Momayez Sanat. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study. Systematic Reviews 2023; 12(1) doi: 10.1186/s13643-023-02299-x
|
| 9 |
Hüseyin Vural, Ferah Armutcu, Omer Akyol, Ralf Weiskirchen. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clinica Chimica Acta 2021; 523: 374 doi: 10.1016/j.cca.2021.10.018
|
| 10 |
Basil Nwaneri Okeahialam, Okechukwu Samuel Ogah. Editorial: Cardiovascular anthropometry for large scale population studies. Frontiers in Cardiovascular Medicine 2024; 10 doi: 10.3389/fcvm.2023.1353557
|
| 11 |
Jonathan Zhi Kai Toh, Xin-Hui Pan, Phoebe Wen Lin Tay, Cheng Han Ng, Jie Ning Yong, Jieling Xiao, Jin Hean Koh, En Ying Tan, Eunice Xiang Xuan Tan, Yock Young Dan, Poay Huan Loh, Roger Foo, Nicholas W.S. Chew, Arun J. Sanyal, Mark D. Muthiah, Mohammad Shadab Siddiqui. A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2022; 20(11): 2462 doi: 10.1016/j.cgh.2021.09.021
|
| 12 |
E.P. Smuglov, E.V. Maksimova, D.G. Pashkovsky. Features of the management of coronary heart disease in patients with metabolically associated fatty liver disease. THE NEW ARMENIAN MEDICAL JOURNAL 2023; (2, 17 (2023)): 28 doi: 10.56936/18290825-2023.17.2-28
|
| 13 |
Ximing Wang, Jingxiang Sun, Na Chang, Menghan Liu, Shuai Zhang. Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study. BMC Medical Imaging 2025; 25(1) doi: 10.1186/s12880-025-01559-7
|
| 14 |
Qian Zhang, Wei Zhang, Jing Liu, Haisen Yang, Yuxia Hu, Mengdi Zhang, Tuya Bai, Fuhou Chang. Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway. Bioengineered 2021; 12(1): 4520 doi: 10.1080/21655979.2021.1956671
|
| 15 |
Ya. Ya. Ihnatko, M. A. Derbak, K. I. Chubirko, O. M. Moskal. FEATURES OF THE FUNCTIONAL STATE OF THE LIVER AND INDICATORS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Bulletin of Problems Biology and Medicine 2024; 1(1): 156 doi: 10.29254/2077-4214-2024-1-172-156-161
|
| 16 |
I.O. Pilat, I.M. Skrypnyk . IMPACT OF CORONARY ARTERY DISEASE ON STEATOTIC LIVER DISEASE PROGRESSION. Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 2024; 24(2): 44 doi: 10.31718/2077-1096.24.2.44
|
| 17 |
Fei Guo, Rui Chen, Linghui Kong, Pan Wei, Ziyu Liu, Xiaoqing Wang, Hairong Hao, Yanwen Lu, Wen Hu. Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease. Hepatology International 2022; 16(6): 1424 doi: 10.1007/s12072-022-10387-8
|
| 18 |
Yan Li, Li Li, Hua Zhao, Xiwen Gao, Shanqun Li, Xiaotong Yang. The Identification and Clinical Value Evaluation of CYCS Related to Asthma through Bioinformatics Analysis and Functional Experiments. Disease Markers 2023; 2023: 1 doi: 10.1155/2023/5746940
|
| 19 |
D. V. Garbuzenko, D. V. Belov. Non-alcoholic fatty liver disease as an independent factor of cardiometabolic risk of cardiovascular diseases. Experimental and Clinical Gastroenterology 2021; (10): 22 doi: 10.31146/1682-8658-ecg-194-10-22-34
|
| 20 |
Wen Wen, Hua Fan, Shenghui Zhang, Siqi Hu, Chen Chen, Jiake Tang, Yao You, Chunyi Wang, Jie Li, Lin Luo, Yongran Cheng, Mengyun Zhou, Xuezhi Zhao, Tao Tan, Fangfang Xu, Xinyan Fu, Juan Chen, Peng Dong, Xingwei Zhang, Mingwei Wang, Yan Feng. Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease. The American Journal of the Medical Sciences 2024; 368(6): 557 doi: 10.1016/j.amjms.2024.06.022
|
| 21 |
Jeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, Kristian L. Funck, Esben Søndergaard, Rakel F. Johansen, Steffen Ringgaard, Lars P. Tolbod, Mogens Johannsen, Helle L. Kanstrup, Henning Grønbæk, Jan Frystyk, Lars C. Gormsen, Søren Nielsen. Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease. Atherosclerosis 2023; 372: 10 doi: 10.1016/j.atherosclerosis.2023.03.015
|
| 22 |
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Camelia Cristina Diaconu. Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk. Biomolecules 2025; 15(2): 163 doi: 10.3390/biom15020163
|
| 23 |
A. Yu. Ryabova, I. V. Kozlova, T. G. Shapovalova, M. M. Shashina. Comorbidity of gastroenterological and cardiovascular pathology as a problem of clinical practice. Experimental and Clinical Gastroenterology 2022; (3): 107 doi: 10.31146/16828658-ecg-199-3-107-114
|
| 24 |
Xiaohan Wang, Liang Shen, Yueyu Shen, Feng Han, Zizhong Ji. Association between Non-alcoholic Fatty Liver Disease and the Severity of Coronary Artery Stenosis in Eastern Chinese Population. Hepatitis Monthly 2022; 21(11) doi: 10.5812/hepatmon.122772
|
| 25 |
Dongli Han, Haiying Zhang, Shousheng Liu, Likun Zhuang, Zhenzhen Zhao, Hongguang Ding, Yongning Xin. Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02385-9
|